Gautret, P, et al.
Emerging viral respiratory tract infections-environmental risk factors and transmission. Lancet Infectious Diseases
2014; 14: 1113–1122.
Chowell, G, et al.
Transmission potential of influenza A/H7N9, February to May 2013, China. BMC Medicine
2013; 11: 214.
Beigel, JH, et al.
Avian influenza A (H5N1) infection in humans. New England Journal of Medicine
2005; 353: 1374–1385.
Husain, M. Avian influenza A (H7N9) virus infection in humans: epidemiology, evolution, and pathogenesis. Infection, Genetics and Evolution
2014; 28: 304–312.
Li, Q, et al.
Epidemiology of human infections with avian influenza A(H7N9) virus in China. New England Journal of Medicine
2014; 370: 520–532.
Kaplan, BS, Webby, RJ. The avian and mammalian host range of highly pathogenic avian H5N1 influenza. Virus Research
2013; 178: 3–11.
Yuan, R, et al.
Pathogenicity and transmission of H5N1 avian influenza viruses in different birds. Veterinary Microbiology
2014; 168: 50–59.
Belser, JA, et al.
Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic avian influenza A (H7N3) virus associated with human conjunctivitis. Journal of Virology
2013; 87: 5746–5754.
Chan, MC, et al.
Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract. Lancet Respiratory Medicine
2013; 1: 534–542.
Webster, RG, Govorkova, EA. Continuing challenges in influenza. Annals of the New York Academy of Sciences
2014; 1323: 115–139.
Hurt, AC, et al.
Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model. Antiviral Research
2010; 87: 361–366.
Bertran, K, et al.
Pathogenesis and transmissibility of highly (H7N1) and low (H7N9) pathogenic avian influenza virus infection in red-legged partridge (Alectoris rufa). Veterinary Research
2011; 42: 24.
Brown, JD, Poulson, R, Stallknecht, DE. Wild bird surveillance for avian influenza virus. Methods in Molecular Biology
2014; 1161: 69–81.
Fournie, G, et al.
Identifying live bird markets with the potential to act as reservoirs of avian influenza A (H5N1) virus: a survey in northern Viet Nam and Cambodia. PLoS ONE
2012; 7: e37986.
Pérez-Ramírez, E, et al.
Detection of low pathogenic avian influenza viruses in wild birds in Castilla-La Mancha (south central Spain). Veterinary Microbiology
2010; 146: 200–208.
Yang, Y, et al.
Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014. Eurosurveillance
2015; 20: pii=21056.
Kucharski, A, et al.
Distinguishing between reservoir exposure and human-to-human transmission for emerging pathogens using case onset data. PLoS Currents
2014; 6: pii.
Kucharski, AJ, Edmunds, WJ. Characterizing the transmission potential of zoonotic infections from minor outbreaks. PLoS Computational Biology
2015; 11: e1004154.
Aditama, TY, et al.
Avian influenza H5N1 transmission in households, Indonesia. PLoS ONE
2012; 7: e29971.
Ahmed, MS, et al.
Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection. Antiviral Research
Bai, T, Zhou, J, Shu, Y. Serologic study for influenza A (H7N9) among high-risk groups in China. New England Journal of Medicine
2013; 368: 2339–2340.
Xiong, C, et al.
Serological study of antibodies to influenza A viruses among general population in Wuhan city China. Journal of Clinical Virology
2014; 61: 178–179.
Lazarus, R, Lim, PL. Avian influenza: recent epidemiology, travel-related risk, and management. Current Infectious Disease Reports
2014; 17: 1–9.
Lam, TT, et al.
Dissemination, divergence and establishment of H7N9 influenza viruses in China. Nature
2015; 522: 102–105.
Liu, Y, et al.
The third wave: H7N9 endemic reassortant viruses and patient clusters. Journal of Infection in Developing Countries
2015. 9: 122–127.
Yi, L, et al.
Family clusters of Avian influenza A H7N9 virus infection in Guangdong province, China. Journal of Clinical Microbiology
2015; 53: 22–28.
Xu, C, et al.
Monitoring avian influenza A(H7N9) virus through national influenza-like illness surveillance, China. Emerging Infectious Diseases
2013; 19: 1289–1292.
Gao, R, et al.
Human infection with a novel avian-origin influenza A (H7N9) virus. New England Journal of Medicine
2013; 368: 1888–1897.
Cowling, BJ, et al.
Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet
2013; 382: 129–137.
European Centre for Disease Prevention and Control. Human infection with avian influenza A(H7N9) virus –fourth update. Rapid Risk Assessment
Wang, C, et al.
Comparison of patients hospitalized with influenza a subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clinical Infectious Diseases
2014; 58: 1095–1103.
Yang, Y, et al.
Novel avian-origin influenza A (H7N9) in critically ill patients in China. Critical Care Medicine
2014; 43: 339–345.
Ji, H, et al.
Epidemiological and clinical characteristics and risk factors for death of patients with avian influenza a H7N9 virus infection from Jiangsu province, Eastern China. PLoS ONE
2014; 9: e89581
Watanabe, T, et al.
Pandemic potential of avian influenza A (H7N9) viruses. Trends in Microbiology
2014; 22: 623–631.
Siston, AM, et al.
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. Journal of the American Medical Association
2010; 303: 1517–1525.
Guo, Q, et al.
Delivery of fetus death with misoprostol in a pregnant woman with H7N9 avian influenza A virus pneumonia and ARDS. Critical Care
2014; 18: 589.
Qi, X, et al.
Avian influenza A(H7N9) virus infection in pregnant woman, China, 2013. Emerging Infectious Diseases
2014; 20: 333–334.
Qian, W, et al.
Kinetic analysis of the immunity in a pregnant patient infected with avian influenza H7N9. International Journal of Clinical and Experimental Medicine
2014; 7: 1768–1774.
Hu, Y, et al.
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet
2013; 381: 2273–2279.
To, KK, Chan, JF, Yuen, KY. Viral lung infections: epidemiology, virology, clinical features, and management of avian influenza A(H7N9). Current Opinion in Pulmonary medicine
2014; 20: 225–232.
Gao, HN, et al.
Clinical findings in 111 cases of influenza A (H7N9) virus infection. New England Journal of Medicine
2013; 368: 2277–2285.
Hai, R, et al.
Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nature Communications
2013; 4: 2854.
Liu, Q, et al.
Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-alpha for infection control and treatment. Expert Review of Anti-infective Therapy
2014; 12: 165–169.
Sleeman, K, et al.
R292 K substitution and drug susceptibility of influenza A(H7N9) viruses. Emerging Infectious Diseases
2013; 19: 1521–1524.
Furuta, Y, et al.
Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Research
2013; 100: 446–454.
Marjuki, H, et al.
An investigational antiviral drug, DAS181, effectively inhibits replication of zoonotic influenza A virus subtype H7N9 and protects mice from lethality. Journal of Infectious Diseases
2014; 210: 435–440.
Lu, S, et al.
Analysis of the clinical characteristics and treatment of two patients with avian influenza virus (H7N9). Bioscience Trends
2013; 7: 109–112.
To, KK, et al.
The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infectious Diseases
2013; 13: 809–821.
Wiwanitkit, V. H7N9 influenza: The emerging infectious disease. North American Journal of Medical Sciences
2013; 5: 395–398.
Xi, X, et al.
Avian influenza A (H7N9) infections: intensivists as virus hunters in the new century. Journal of Critical Care
2013; 28: 528–530.
World Health Organization Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness, 26 February, 2015. Accessed 15 May 2015.
Abdelwhab, EM, Veits, J, Mettenleiter, TC. Prevalence and control of H7 avian influenza viruses in birds and humans. Epidemiology and Infection
2014; 142: 896–920.
Zhao, B, et al.
Novel avian influenza A(H7N9) virus in tree sparrow, Shanghai, China, 2013. Emerging Infectious Diseases
2014; 20: 850–853.
Zambon, M. Influenza and other emerging respiratory viruses. Medicine (United Kingdom)
2014; 42: 45–51.
Ding, H, et al.
Epidemiologic characterization of 30 confirmed cases of human infection with avian influenza A(H7N9) virus in Hangzhou, China. BMC Infectious Diseases
2014; 14: 175.
Abolnik, C. A current review of avian influenza in pigeons and doves (Columbidae). Veterinary Microbiology
2014; 170: 181–196.
Chen, Z, et al.
Detection of avian influenza A(H7N9) virus from live poultry markets in Guangzhou, China: a surveillance report. PLoS ONE
2014; 9: e107266.
Wang, C, et al.
Relationship between domestic and wild birds in live poultry market and a novel human H7N9 virus in China. Journal of Infectious Diseases
2014; 209: 34–37.
Ai, J, et al.
Case-control study of risk factors for human infection with influenza A(H7N9) virus in Jiangsu Province, China, 2013. Eurosurveillance
2013; 18: 20510.
Zhang, Y, et al.
The impact of temperature and humidity measures on influenza A (H7N9) outbreaks-evidence from China. International Journal of Infectious Diseases
2015; 30: 122–124.
Brown, JD, et al.
Avian influenza virus in water: infectivity is dependent on pH, salinity and temperature. Veterinary Microbiology
2009; 136: 20–26.
Zou, S, et al.
Inactivation of the novel avian influenza A (H7N9) virus under physical conditions or chemical agents treatment. Virology Journal
2013; 10: 289.
Belser, JA, et al.
Influenza A virus transmission: contributing factors and clinical implications. Expert Reviews in Molecular Medicine
Xiong, X, McCauley, JW, Steinhauer, DA. Receptor binding properties of the influenza virus hemagglutinin as a determinant of host range. Current Topics in Microbiology and Immunology
2014; 385: 63–91.
Zhou, J, et al.
Biological features of novel avian influenza A (H7N9) virus. Nature
2013; 499: 500–503.
Xiong, X, et al.
Receptor binding by an H7N9 influenza virus from humans. Nature
2013; 499: 496–499.
de Graaf, M, Fouchier, RA. Role of receptor binding specificity in influenza A virus transmission and pathogenesis. EMBO Journal
2014; 33: 823–841.
Knepper, J, et al.
The novel human influenza A(H7N9) virus is naturally adapted to efficient growth in human lung tissue. mBio
2013; 4: e00601–00613.
Gabbard, JD, et al.
Novel H7N9 influenza virus shows low infectious dose, high growth rate, and efficient contact transmission in the guinea pig model. Journal of Virology
2014; 88: 1502–1512.
Bi, Y, et al.
Assessment of the internal genes of influenza A (H7N9) virus contributing to high pathogenicity in mice. Journal of Virology
2015; 89: 2–13.
Jonges, M, et al.
Emergence of the virulence-associated PB2 E627 K substitution in a fatal human case of highly pathogenic avian influenza virus A(H7N7) infection as determined by Illumina ultra-deep sequencing. Journal of Virology
2014; 88: 1694–1702.
Xu, W, et al.
Serological investigation of subclinical influenza A(H7H9) infection among healthcare and non-healthcare workers in Zhejiang province, China. Clinical Infectious Diseases
2013; 57: 919–921.
Watanabe, T, et al.
Characterization of H7N9 influenza A viruses isolated from humans. Nature
2013; 501: 551–555.
Meijer, A, et al.
Measurement of antibodies to avian influenza virus A(H7N7) in humans by hemagglutination inhibition test. Journal of Virological Methods
2006; 132: 113–120.
De Groot, AS, et al.
Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design. Human Vaccines & Immunotherapeutics
2013; 9: 950–956.
Qi, X, et al.
Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. British Medical Journal
2013; 347: f4752.
Belser, JA, et al.
Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature
2013; 501: 556–559.
Zhu, H, et al.
Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science
2013; 341: 183–186.
Richard, M, et al.
Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature
2013; 501: 560–563.
Xu, L, et al.
Novel avian-origin human influenza A(H7N9) can be transmitted between ferrets via respiratory droplets. Journal of Infectious Diseases
2014; 209: 551–556.
Zhang, Q, et al.
H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science
2013; 341: 410–414.
Zhu, Y, et al.
Human co-infection with novel avian influenza A H7N9 and influenza A H3N2 viruses in Jiangsu province, China. Lancet
2013; 381: 2134.
Ke, C, et al.
Circulation of reassortant influenza A(H7N9) viruses in poultry and humans, Guangdong Province, China, 2013. Emerging Infectious Diseases
2014; 20: 2034–2040.
Meng, Z, et al.
Possible pandemic threat from new reassortment of influenza A(H7N9) virus in China. Eurosurveillance
2014; 19: pii=20699.
Ferguson, NM, et al.
Public health. Public health risk from the avian H5N1 influenza epidemic. Science
2004; 304: 968–969.
Nishiura, H, Mizumoto, K, Ejima, K. How to interpret the transmissibility of novel influenza A(H7N9): An analysis of initial epidemiological data of human cases from China. Theoretical Biology and Medical Modelling
2013; 10: 30.
Xiao, Y, et al.
Transmission potential of the novel avian influenza A(H7N9) infection in mainland China. Journal of Theoretical Biology
2014; 352: 1–5.
Kucharski, AJ, Edmunds, WJ. Cross-immunity and age patterns of influenza A(H5N1) infection. Epidemiology and Infection
2015; 143: 1119–1124.
Fraser, C, et al.
Pandemic potential of a strain of influenza A (H1N1): early findings. Science
2009; 324: 1557–1561.
Yang, Y, et al.
The transmissibility and control of pandemic influenza A (H1N1) virus. Science
2009; 326: 729–733.
Van Kerkhove, MD, et al.
Epidemiologic and virologic assessment of the 2009 influenza A (H1N1) pandemic on selected temperate countries in the Southern Hemisphere: Argentina, Australia, Chile, New Zealand and South Africa. Influenza and Other Respiratory Viruses
2011; 5: e487–e498.
Fang, LQ, et al.
Mapping spread and risk of avian influenza A (H7N9) in China. Scientific Reports
2013; 3: 2722.
Shi, B, et al.
Inferring the potential risks of H7N9 infection by spatiotemporally characterizing bird migration and poultry distribution in eastern China. Infectious Diseases of Poverty
2013; 2: 8.
Rivers, C, et al.
Estimating human cases of avian influenza A(H7N9) from poultry exposure. PLoS Currents
2013; 5: pii.
De Nardi, M, et al. Development of a risk assessment methodological framework for potentially pandemic influenza strains (FLURISK). European Food Safety Authority, 2013; EFSA supporting publication 2014: EN–571.
Cox, NJ, Trock, SC, Burke, SA. Pandemic preparedness and the Influenza Risk Assessment Tool (IRAT). Current Topics in Microbiology and Immunology
2014; 385: 119–136.
Liu, W, et al.
Spatial and temporal analysis of human infection with avian influenza A(H7N9) virus in China, 2013. Eurosurveillance
2013; 18: pii: 20640.
Qiu, J, et al.
Spatiotemporal pattern and risk factors of the reported novel avian-origin influenza A(H7N9) cases in China. Preventive Veterinary Medicine
2014; 115: 229–237.
Fuller, T, et al.
Identifying areas with a high risk of human infection with the avian influenza A (H7N9) virus in East Asia. Journal of Infection
2014; 69: 174–181.
Gilbert, M, et al.
Predicting the risk of avian influenza A H7N9 infection in live-poultry markets across Asia. Nature Communications
2014; 5: 4116.
Yu, H, et al.
Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study. Lancet
2014; 383: 541–548.
Liu, S, et al.
Global dynamics of avian influenza epidemic models with psychological effect. Computational and Mathematical Methods in Medicine
2015; 2015: 1–12.
Hsieh, YH, et al.
Quantification of bird-to-bird and bird-to-human infections during 2013 novel H7N9 avian influenza outbreak in China. PLoS ONE
2014; 9: e111834.
Van Kerkhove, MD, et al.
Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries. Influenza and Other Respiratory Viruses
2013; 7: 872–886.
Eibach, D, et al.
Routes of transmission during a nosocomial influenza A(H3N2) outbreak among geriatric patients and healthcare workers. Journal of Hospital Infection
2014; 86: 188–193.
Lo, YC, et al.
Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011–12 season. PLoS ONE
2013; 8: e58222.